12 September 2014

What Y'all Are Prayin' About. Thank you.

On the Kubler-Ross DABDA Model*, this post MIGHT mean I'm moving from and/or in and/or out of the anger stage into the acceptance stage. 

I reserve the right to move in and out of the anger stage, possibly at random.

Triple Negative Breast Cancer 



What is Triple Negative Breast Cancer?

A diagnosis of triple negative breast cancer means that the three most common types of receptors known to fuel most breast cancer growth–estrogen, progesterone, and the HER-2/neu gene– are not present in the cancer tumor.  This means that the breast cancer cells have tested negative for hormone epidermal growth factor receptor 2 (HER-2), estrogen receptors (ER), and progesterone receptors (PR).  Since the tumor cells lack the necessary receptors, common treatments like hormone therapy and drugs that target estrogen, progesterone, and HER-2 are ineffective. Using chemotherapy to treat triple negative breast cancer is still an effective option. In fact, triple negative breast cancer may respond even better to chemotherapy in the earlier stages than many other forms of cancer.

breast cancer triple negative cell

breast cancer triple negative percentage

Who is at risk for Triple Negative Breast Cancer?

Triple negative breast cancer occurs in about 10-20% of diagnosed breast cancers and is more likely to affect younger people, African Americans, Hispanics, and/or those with a BRCA1 gene mutation.



Triple negative breast cancer can be more aggressive and difficult to treat.  Also, the cancer is more likely to spread and recur.  The stage of breast cancer and the grade of the tumor will influence your prognosis.

*Kubler-Ross Model:

Let Me Know What You Think!

HTML Comment Box is loading comments...